vs

Side-by-side financial comparison of DYADIC INTERNATIONAL INC (DYAI) and Iveda Solutions, Inc. (IVDA). Click either name above to swap in a different company.

Iveda Solutions, Inc. is the larger business by last-quarter revenue ($626.0K vs $565.5K, roughly 1.1× DYADIC INTERNATIONAL INC). Iveda Solutions, Inc. runs the higher net margin — -258.6% vs -277.1%, a 18.5% gap on every dollar of revenue. On growth, DYADIC INTERNATIONAL INC posted the faster year-over-year revenue change (-30.8% vs -64.1%). Over the past eight quarters, Iveda Solutions, Inc.'s revenue compounded faster (34.4% CAGR vs 30.0%).

Dyadic International Inc is a global biotechnology firm that develops and manufactures proprietary high-performance enzymes, biologic therapies and sustainable bioproducts. It serves pharma, industrial biotech, agricultural and environmental sectors across North America, Europe and Asia Pacific, using its patented C1 gene expression platform to drive cost-effective scalable biomanufacturing.

Iveda Solutions, Inc. is a technology provider specializing in cloud-based AI video surveillance, IoT-enabled smart sensing, and integrated smart city solutions. It serves public sector, enterprise, and education clients across North America and Asia, with core offerings covering remote security monitoring, smart facility management, and real-time data analysis tools for public safety use cases.

DYAI vs IVDA — Head-to-Head

Bigger by revenue
IVDA
IVDA
1.1× larger
IVDA
$626.0K
$565.5K
DYAI
Growing faster (revenue YoY)
DYAI
DYAI
+33.2% gap
DYAI
-30.8%
-64.1%
IVDA
Higher net margin
IVDA
IVDA
18.5% more per $
IVDA
-258.6%
-277.1%
DYAI
Faster 2-yr revenue CAGR
IVDA
IVDA
Annualised
IVDA
34.4%
30.0%
DYAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DYAI
DYAI
IVDA
IVDA
Revenue
$565.5K
$626.0K
Net Profit
$-1.6M
$-1.6M
Gross Margin
3.6%
Operating Margin
-271.6%
-262.7%
Net Margin
-277.1%
-258.6%
Revenue YoY
-30.8%
-64.1%
Net Profit YoY
-1.1%
-7.1%
EPS (diluted)
$-0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DYAI
DYAI
IVDA
IVDA
Q4 25
$565.5K
$626.0K
Q3 25
$1.2M
$1.7M
Q2 25
$966.6K
$1.5M
Q1 25
$393.6K
$1.5M
Q4 24
$817.4K
$1.7M
Q3 24
$2.0M
$2.4M
Q2 24
$385.9K
$1.5M
Q1 24
$334.6K
$346.8K
Net Profit
DYAI
DYAI
IVDA
IVDA
Q4 25
$-1.6M
$-1.6M
Q3 25
$-2.0M
$-221.3K
Q2 25
$-1.8M
$-564.2K
Q1 25
$-2.0M
$-793.7K
Q4 24
$-1.6M
$-1.5M
Q3 24
$-203.5K
$-581.4K
Q2 24
$-2.0M
$-599.0K
Q1 24
$-2.0M
$-1.3M
Gross Margin
DYAI
DYAI
IVDA
IVDA
Q4 25
3.6%
Q3 25
12.1%
31.3%
Q2 25
29.1%
Q1 25
19.5%
Q4 24
56.8%
11.9%
Q3 24
79.8%
17.1%
Q2 24
21.8%
32.7%
Q1 24
57.0%
52.5%
Operating Margin
DYAI
DYAI
IVDA
IVDA
Q4 25
-271.6%
-262.7%
Q3 25
-165.3%
-13.0%
Q2 25
-178.9%
-34.8%
Q1 25
-508.8%
-56.7%
Q4 24
-187.2%
-87.3%
Q3 24
-10.4%
-25.4%
Q2 24
-529.3%
-39.7%
Q1 24
-635.2%
-384.1%
Net Margin
DYAI
DYAI
IVDA
IVDA
Q4 25
-277.1%
-258.6%
Q3 25
-169.7%
-13.4%
Q2 25
-185.6%
-36.9%
Q1 25
-515.2%
-53.8%
Q4 24
-189.7%
-86.7%
Q3 24
-10.4%
-24.2%
Q2 24
-530.0%
-39.0%
Q1 24
-600.6%
-371.9%
EPS (diluted)
DYAI
DYAI
IVDA
IVDA
Q4 25
$-0.33
Q3 25
$-0.06
$-0.07
Q2 25
$-0.06
$-0.20
Q1 25
$-0.28
Q4 24
$-0.60
Q3 24
$-0.01
$-0.27
Q2 24
$-0.07
$-0.30
Q1 24
$-0.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DYAI
DYAI
IVDA
IVDA
Cash + ST InvestmentsLiquidity on hand
$7.3M
$5.2M
Total DebtLower is stronger
$393.4K
Stockholders' EquityBook value
$1.2M
$4.8M
Total Assets
$9.9M
$6.4M
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DYAI
DYAI
IVDA
IVDA
Q4 25
$7.3M
$5.2M
Q3 25
$8.9M
$3.3M
Q2 25
$5.0M
$1.6M
Q1 25
$7.4M
$2.5M
Q4 24
$9.3M
$2.6M
Q3 24
$5.9M
$3.6M
Q2 24
$6.1M
$2.9M
Q1 24
$10.6M
$3.9M
Total Debt
DYAI
DYAI
IVDA
IVDA
Q4 25
$393.4K
Q3 25
$306.4K
Q2 25
$365.3K
Q1 25
$340.8K
Q4 24
$376.2K
Q3 24
$545.9K
Q2 24
$564.0K
Q1 24
$480.0K
Stockholders' Equity
DYAI
DYAI
IVDA
IVDA
Q4 25
$1.2M
$4.8M
Q3 25
$2.6M
$3.8M
Q2 25
$-529.7K
$1.5M
Q1 25
$923.6K
$1.7M
Q4 24
$2.5M
$2.5M
Q3 24
$3.4M
$4.1M
Q2 24
$3.2M
$2.8M
Q1 24
$4.5M
$3.3M
Total Assets
DYAI
DYAI
IVDA
IVDA
Q4 25
$9.9M
$6.4M
Q3 25
$11.7M
$5.8M
Q2 25
$8.1M
$4.4M
Q1 25
$7.9M
$4.5M
Q4 24
$9.9M
$5.2M
Q3 24
$10.8M
$9.1M
Q2 24
$10.6M
$6.8M
Q1 24
$12.7M
$6.6M
Debt / Equity
DYAI
DYAI
IVDA
IVDA
Q4 25
0.08×
Q3 25
0.08×
Q2 25
0.25×
Q1 25
0.20×
Q4 24
0.15×
Q3 24
0.13×
Q2 24
0.20×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DYAI
DYAI
IVDA
IVDA
Operating Cash FlowLast quarter
$-1.8M
$-252.4K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DYAI
DYAI
IVDA
IVDA
Q4 25
$-1.8M
$-252.4K
Q3 25
$-1.9M
$-317.0K
Q2 25
$-130.0K
$-1.3M
Q1 25
$-1.9M
$-126.0K
Q4 24
$-696.4K
$-889.8K
Q3 24
$-201.1K
$-1.2M
Q2 24
$-2.0M
$-999.7K
Q1 24
$-1.1M
$-1.3M
Free Cash Flow
DYAI
DYAI
IVDA
IVDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-889.8K
Q3 24
$-1.5M
Q2 24
$-1.1M
Q1 24
$-1.5M
FCF Margin
DYAI
DYAI
IVDA
IVDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-51.1%
Q3 24
-64.1%
Q2 24
-72.6%
Q1 24
-427.3%
Capex Intensity
DYAI
DYAI
IVDA
IVDA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
Q3 24
12.5%
Q2 24
7.5%
Q1 24
54.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons